CD274 and neoplasm: Moreover, MC38-hPD-L1/hCD47 in humanized B-hPD-L1/hCD47/hSIRPα triple transgenic mouse model was used to evaluate the anti-tumor efficacy of 6MW3211 (Figure 4I).